Remove 2017 Remove Healthcare Remove Prescription
article thumbnail

Biden proposes subsidizing drug middlemen for insulin

World of DTC Marketing

Under the bill proposed, Medicare beneficiaries and those insured through private plans would pay no more than $35 for a 30-day insulin prescription, or the lesser of $35 or 25% of the plan’s negotiated price for a 30-day prescription. This could cost taxpayers billions over the year. 2 by the PBM Accountability Project.

Insurance 240
article thumbnail

New FDA head needs to examine the accelerated approval program

World of DTC Marketing

The analysis focused on Medicare Part B and Part D spending — which covers outpatient medical care and prescription drugs, respectively, — in 2017, 2018 and 2019, the researchers said. This is another example of just how screwed up our healthcare system really is. appeared first on World of DTC Marketing.com.

FDA 234
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What Pear Therapeutics’ Bankruptcy Has Left the DTX Industry to Ponder

MedCity News

One of the fastest-growing frontiers of healthcare is Digital Therapeutics (DTx), which utilizes clinically tested software to prevent, treat, and manage a growing range of medical conditions. The goal was simple: provide access and focused support to patients remotely while simultaneously relieving overtaxed healthcare facilities.

article thumbnail

AbbVie sucks

World of DTC Marketing

The increase followed total Humira price hikes of 19 percent during 2017 and 2018. The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. So how do people who work for AbbVie feel?

article thumbnail

Marketing to physicians

World of DTC Marketing

Deloitte showed there is a significant trust gap between pharmaceutical companies and people working in healthcare. One study analyzed the drug ads of an anti-hypertensive drug in 210 issues of the NEJM between 1985 to 1996 and showed increased ad frequency was associated with an increase in prescriptions. 2017 study.

article thumbnail

Mental health apps and services may be doing more harm than good

World of DTC Marketing

Cerebral will stop writing prescriptions for Adderall, Ritalin, and other controlled substances to new ADHD patients as concerns grow about telehealth companies’ prescribing practices. A body of work published since 2017 suggests that these apps work best when combined with in-person therapy. Here’s a great example.

Patients 252
article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

They are vital to ensuring the safe and effective use of medicines, making them an integral part of healthcare in Europe. It emphasises its ability to make information interoperable with electronic health systems such as e-prescription and electronic health records.